EASL Congress

Across four days in Barcelona, the programme spans the latest advances in liver disease prevention, diagnosis and treatment, with sessions designed to translate new evidence into clinical practice and to support collaboration between academia, healthcare and industry.

Who the audience is and how many attend

Audience

• Hepatologists, gastroenterologists and other clinicians involved in liver disease care
• Researchers and translational scientists in liver biology and disease mechanisms
• Allied health professionals supporting liver care pathways
• Clinical trial teams and drug developers in hepatology
• Industry partners and solution providers across therapeutics, diagnostics and supporting technologies

Scale

• A flagship international liver congress with a large multi-day scientific programme and a significant industry/exhibition presence.
• The organiser does not consistently publish a single fixed headline figure for total attendees, exhibitors/vendors, or main sponsors on the main public overview pages.

What to expect

• A four-day hepatology programme covering cutting-edge research and practice-relevant clinical updates
• Abstract- and data-driven sessions, including late-breaking science and poster presentations
• Opportunities to connect with global experts across liver disease areas and modalities
• A substantial industry presence and networking environment alongside the scientific agenda
• Hybrid access options for delegates attending remotely as well as on-site in Barcelona

Latest Features